carbinoxamine maleate 6 MG Oral Tablet
carbinoxamine maleate
RxCUI: 1795581
What the CMS Formulary Data Shows for carbinoxamine maleate 6 MG Oral Tablet
Per the CMS 2026 Part D formulary file, carbinoxamine maleate 6 MG Oral Tablet (RxNorm concept RXCUI 1795581, generic name carbinoxamine maleate) appears on 2 distinct formulary files spanning 7 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 2, with a cross-plan average of Tier 1.5.
Real-world access to carbinoxamine maleate 6 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,400 Part D beneficiaries filled carbinoxamine maleate 6 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $921,020 and an average per-beneficiary annual cost of $657.87. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry carbinoxamine maleate 6 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 7
- Coverage rate
- 0.1%
- Tier range
- Tier 1 – Tier 2
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,400
- Total spending
- $921,020
- Avg per beneficiary
- $657.87
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering carbinoxamine maleate 6 MG Oral Tablet
7 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Leon MediExtra (HMO) | LEON HEALTH, INC. | T1 | No | $0 | FL |
| Leon MediDual (HMO D-SNP) | LEON HEALTH, INC. | T1 | No | $0 | FL |
| Leon MediMore (HMO) | LEON HEALTH, INC. | T1 | No | $0 | FL |
| Leon MediMax (HMO D-SNP) | LEON HEALTH, INC. | T1 | No | $0 | FL |
| PrimeTime Health Plan Aultimate (HMO-POS) | AULTCARE HEALTH INSURING CORPORATION | T2 | No | $0 | OH |
| PrimeTime Health Plan Plus (HMO-POS) | AULTCARE HEALTH INSURING CORPORATION | T2 | No | $36.00 | OH |
| PrimeTime Health Plan Classic (HMO-POS) | AULTCARE HEALTH INSURING CORPORATION | T2 | No | $40.30 | OH |
Frequently Asked Questions
Is carbinoxamine maleate 6 MG Oral Tablet covered by Medicare Part D?
Yes, carbinoxamine maleate 6 MG Oral Tablet is covered by 7 Medicare Part D plans (0.1% of all Part D formularies).
What tier is carbinoxamine maleate 6 MG Oral Tablet on Medicare Part D plans?
carbinoxamine maleate 6 MG Oral Tablet averages Tier 1.5 across Part D plans, ranging from Tier 1 to Tier 2.
Does carbinoxamine maleate 6 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for carbinoxamine maleate 6 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on carbinoxamine maleate 6 MG Oral Tablet?
In 2023, total Medicare Part D spending on carbinoxamine maleate 6 MG Oral Tablet was $921,020, covering 1,400 beneficiaries. The average spend per beneficiary was $657.87.
Read our methodology - how this data is sourced, computed, and verified.